Advertisement

June 30, 2026

GE’s Allia Upgrade Pathways Introduced for Existing Interventional Suites

KEY TAKEAWAYS

  • GE HealthCare has introduced Allia platform upgrade pathways for select legacy Innova and Discovery imaging guided systems in the United States and other approved markets.
  • The upgrade program is intended to extend the lifespan of existing interventional suites while providing access to newer imaging technologies and workflow capabilities.
  • Available upgrades may include AI-enabled image reconstruction, augmented reality guidance, multimodality imaging, and predictive maintenance tools, depending on system configuration and regulatory status.

June 30, 2026—GE HealthCare announced the introduction of Allia platform upgrade pathways that are designed to help customers modernize select legacy Innova and Discovery image guiding solutions (IGS) systems.

These upgrade pathways are available in the United States and other countries where Allia IGS and Allia IGS Pulse systems are approved and available for sale, advised the company.

According to GE HealthCare, the pathways provide access to Allia technologies and workflows that support efficiency and procedural decision-making while helping preserve existing infrastructure, avoid major construction work, extend interventional room lifetime, and minimize disruption to clinical operations.

The company commented that the upgrade pathways can extend the value of existing systems through workflow enhancements, expanded interoperability capabilities, and access to Allia innovations, while helping reduce infrastructure replacement needs and support long-term operational and sustainability goals.

Through GE HealthCare’s upgrade programs, customers can access technology designed to help enhance image quality, expand imaging capabilities with advanced applications, and streamline workflows across IGS, X-ray, MR, and CT systems.

GE HealthCare stated depending on system configuration, market availability, and applicable regulatory requirements, upgraded options may provide access to capabilities and to third-party solutions including:

  • CleaRecon DL, an artificial intelligence (AI)–enabled deep learning reconstruction technology
  • 3DStent, an intraprocedural tool for three-dimensional visualization of the coronary stent
  • OmnifyXR interventional suite, an augmented reality guidance solution for procedures such as prostate embolization
  • Embo Assist AI, an augmented guidance solution designed to optimize embolization strategies and streamline clinical workflow
  • Medis quantitative flow ratio, a software solution to assess coronary physiology in patients with coronary artery disease
  • Avvigo+ intravascular ultrasound imaging, a multimodality guidance platform that integrates percutaneous coronary intervention tools in the catheterization lab

GE HealthCare also provides Tube Watch and/or OnWatch Predict service options on all upgraded systems to help customers manage system performance and maintenance by providing an AI-powered estimated lead time to failure, noted the press release.

Advertisement


June 30, 2026

FIH AAA Study of Nectero EAST System Evaluates 2-Year Proximal Neck Dynamics

June 30, 2026

Artivion’s AMDS Hybrid Prosthesis Approved by FDA